SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001628280-24-002763
Filing Date
2024-01-31
Accepted
2024-01-31 17:22:16
Documents
9

Document Format Files

Seq Description Document Type Size
1 S-3 arcutis-sx3january2024.htm S-3 484002
2 EX-FILING FEES exhibit107-sx3.htm EX-FILING FEES 47170
3 EX-1.2 exhibit12-sx3.htm EX-1.2 278851
4 EX-4.5 exhibit45-sx3.htm EX-4.5 438095
5 EX-5.1 exhibit51-sx3.htm EX-5.1 41055
6 EX-23.2 exhibit232-sx3.htm EX-23.2 2612
7 lathamlogoa.jpg GRAPHIC 49249
8 logo1aa.jpg GRAPHIC 18410
9 logo1b.jpg GRAPHIC 98116
  Complete submission text file 0001628280-24-002763.txt   1516353
Mailing Address 3027 TOWNSGATE ROAD SUITE 300 WESTLAKE VILLAGE CA 91361
Business Address 3027 TOWNSGATE ROAD SUITE 300 WESTLAKE VILLAGE CA 91361 805-418-5006
Arcutis Biotherapeutics, Inc. (Filer) CIK: 0001787306 (see all company filings)

IRS No.: 812974255 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-276794 | Film No.: 24583986
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)